Prediction of preterm pre-eclampsia and preterm small-for-gestational-age at 24-28 weeks of gestation using ultrasound and biochemical markers in high-risk pregnancies treated with aspirin: A secondary analysis of the StopPRE trial.
OBJECTIVES To evaluate the predictive value of second-trimester clinical ultrasound and biochemical markers for preterm pre-eclampsia and small for gestational age (SGA) in a high-risk population. STUDY DESIGN This secondary analysis included 943 singleton pregnancies from the StopPRE trial. Women classified as high...